{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T14:04:37Z","timestamp":1782828277292,"version":"3.54.5"},"reference-count":31,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2019,5,1]],"date-time":"2019-05-01T00:00:00Z","timestamp":1556668800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pathology - Research and Practice"],"published-print":{"date-parts":[[2019,5]]},"DOI":"10.1016\/j.prp.2019.02.003","type":"journal-article","created":{"date-parts":[[2019,2,2]],"date-time":"2019-02-02T15:35:07Z","timestamp":1549121707000},"page":"977-982","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["Syndecan-1 could be added to hormonal receptors and HER2\/neu in routine assessment of invasive breast carcinoma, relation of its expression to prognosis and clinicopathological parameters"],"prefix":"10.1016","volume":"215","author":[{"given":"Nahed A.","family":"Soliman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shaimaa M.","family":"Yussif","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdelhadi M.","family":"Shebl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.prp.2019.02.003_bib0005","doi-asserted-by":"crossref","first-page":"2137","DOI":"10.1200\/JCO.2005.05.2308","article-title":"Patterns of cancer incidence, mortality, and prevalence across five continents: defining priorities to reduce cancer disparities in different geographic regions of the world","volume":"24","author":"A.W","year":"2006","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.prp.2019.02.003_bib0010","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1038\/nrc2193","article-title":"Modelling breast cancer: one size does not fit all","volume":"7","author":"Vargo-Gogola","year":"2007","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.prp.2019.02.003_bib0015","series-title":"Rosen\u2019s breast pathology","author":"Rosen","year":"2001"},{"key":"10.1016\/j.prp.2019.02.003_bib0020","series-title":"Pathol. Breast","first-page":"426","article-title":"Invasive lobular carcinoma","author":"FA","year":"1999"},{"key":"10.1016\/j.prp.2019.02.003_bib0025","first-page":"3219","article-title":"Molecular subtyping of breast cancer: opportunities for new therapeutic approaches","volume":"64","author":"M.R","year":"2007","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.prp.2019.02.003_bib0030","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1002\/cncr.11515","article-title":"High syndecan-1 expression in breast carcinoma is related to an aggressive phenotype and to poorer prognosis","volume":"98","author":"Barbareschi","year":"2003","journal-title":"Cancer"},{"key":"10.1016\/j.prp.2019.02.003_bib0035","doi-asserted-by":"crossref","first-page":"111444","DOI":"10.18632\/oncotarget.22820","article-title":"Clinicopathological and prognostic significance of SDC1 overexpression in breast cancer","volume":"8","author":"Cui","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.prp.2019.02.003_bib0040","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1309\/AJCPZ1D8CALHDXCJ","article-title":"Syndecan-1 overexpression is associated with nonluminal subtypes and poor prognosis in advanced breast cancer","volume":"140","author":"Nguyen","year":"2013","journal-title":"Am. J. Clin. Pathol."},{"key":"10.1016\/j.prp.2019.02.003_bib0045","doi-asserted-by":"crossref","first-page":"1548","DOI":"10.1016\/j.cellsig.2009.05.001","article-title":"Proteoglycan signaling co-receptors: roles in cell adhesion, migration and invasion","volume":"21","author":"B.G","year":"2009","journal-title":"Cell. Signal."},{"key":"10.1016\/j.prp.2019.02.003_bib0050","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1146\/annurev.biochem.68.1.729","article-title":"Functions of cell surface heparan sulfate proteoglycans","volume":"68","author":"Bernfield","year":"1999","journal-title":"Annu. Rev. Biochem."},{"key":"10.1016\/j.prp.2019.02.003_bib0055","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1054\/bjoc.2001.2054","article-title":"Heparan sulfate proteoglycans and cancer","volume":"85","author":"Blackhall","year":"2001","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.prp.2019.02.003_bib0060","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1369\/0022155411405057","article-title":"Syndecan-1 and syndecan-4 are independent indicators in breast carcinoma","volume":"59","author":"Lendorf","year":"2011","journal-title":"J. Histochem. Cytochem."},{"issue":"Pt 11","key":"10.1016\/j.prp.2019.02.003_bib0065","doi-asserted-by":"crossref","first-page":"2975","DOI":"10.1242\/jcs.107.11.2975","article-title":"Function of the syndecans\u2013a family of cell surface proteoglycans","volume":"107","author":"Elenius","year":"1994","journal-title":"J. Cell Sci."},{"key":"10.1016\/j.prp.2019.02.003_bib0070","doi-asserted-by":"crossref","first-page":"1993","DOI":"10.1038\/sj.bjc.6604400","article-title":"Prognostic impact of syndecan-1 expression in invasive ductal breast carcinomas","volume":"98","author":"Loussouarn","year":"2008","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.prp.2019.02.003_bib0075","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1007\/s10549-005-9135-2","article-title":"Syndecan-1 and syndecan-4 are overexpressed in an estrogen receptor-negative, highly proliferative breast carcinoma subtype","volume":"98","author":"Baba","year":"2006","journal-title":"Breast Cancer Res. Treat."},{"key":"10.1016\/j.prp.2019.02.003_bib0080","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1093\/ajcp\/112.3.377","article-title":"Syndecan-1 expression is induced in the stroma of infiltrating breast carcinoma","volume":"112","author":"Stanley","year":"1999","journal-title":"Am. J. Clin. Pathol."},{"key":"10.1016\/j.prp.2019.02.003_bib0085","doi-asserted-by":"crossref","first-page":"468","DOI":"10.11622\/smedj.2014115","article-title":"Syndecan-1 is a potential biomarker for triple-positive breast carcinomas in asian women with correlation to survival","volume":"55","author":"Lim","year":"2014","journal-title":"Singapore Med. J."},{"key":"10.1016\/j.prp.2019.02.003_bib0090","first-page":"3607","article-title":"Significance of syndecan-1 expression in ductal carcinoma in situ of the breast","volume":"34","author":"Tiemann","year":"2014","journal-title":"Anticancer Res."},{"key":"10.1016\/j.prp.2019.02.003_bib0095","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1007\/s00292-013-1841-7","article-title":"[Invasive breast cancer: the current WHO classification]","volume":"35","author":"Lebeau","year":"2014","journal-title":"Pathologe"},{"key":"10.1016\/j.prp.2019.02.003_bib0100","doi-asserted-by":"crossref","first-page":"3153","DOI":"10.1200\/JCO.2007.15.5986","article-title":"Prognostic significance of Nottingham histologic grade in invasive breast carcinoma","volume":"26","author":"Rakha","year":"2008","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.prp.2019.02.003_bib0105","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1097\/PAI.0b013e318268a93f","article-title":"No-cost manual method for preparation of tissue microarrays having high quality comparable to semiautomated methods","volume":"21","author":"Foda","year":"2013","journal-title":"Appl. Immunohistochem. Mol. Morphol. AIMM"},{"key":"10.1016\/j.prp.2019.02.003_bib0110","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1186\/1746-1596-6-117","article-title":"An inexpensive method of small paraffin tissue microarrays using mechanical pencil tips","volume":"6","author":"Shebl","year":"2011","journal-title":"Diagn. Pathol."},{"key":"10.1016\/j.prp.2019.02.003_bib0115","doi-asserted-by":"crossref","first-page":"496","DOI":"10.20892\/j.issn.2095-3941.2016.0066","article-title":"Ki-67 as a prognostic marker according to breast cancer molecular subtype","volume":"13","author":"Soliman","year":"2016","journal-title":"Cancer Biol. Med."},{"key":"10.1016\/j.prp.2019.02.003_bib0120","series-title":"Assessment of Neuroendocrine Markers in Different Molecular Subtypes of Invasive Breast Carcinoma and Its Impact on Prognosis","author":"Yussif","year":"2018"},{"key":"10.1016\/j.prp.2019.02.003_bib0125","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1245\/s10434-012-2588-8","article-title":"Effect of ASCO\/CAP guidelines for determining ER status on molecular subtype","volume":"20","author":"Deyarmin","year":"2013","journal-title":"Ann. Surg. Oncol."},{"key":"10.1016\/j.prp.2019.02.003_bib0130","doi-asserted-by":"crossref","first-page":"3997","DOI":"10.1200\/JCO.2013.50.9984","volume":"31","author":"Wolff","year":"2013","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.prp.2019.02.003_bib0135","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.anndiagpath.2010.06.010","article-title":"Breast carcinomas with isolated bone metastases have different hormone receptor expression profiles than those with metastases to other sites or multiple organs","volume":"15","author":"Wei","year":"2011","journal-title":"Ann. Diagn. Pathol."},{"key":"10.1016\/j.prp.2019.02.003_bib0140","doi-asserted-by":"crossref","first-page":"2492","DOI":"10.1001\/jama.295.21.2492","article-title":"Race, breast cancer subtypes, and survival in the Carolina Breast Cancer study","volume":"295","author":"Carey","year":"2006","journal-title":"JAMA"},{"key":"10.1016\/j.prp.2019.02.003_bib0145","doi-asserted-by":"crossref","first-page":"10869","DOI":"10.1073\/pnas.191367098","article-title":"Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications","volume":"98","author":"S\u00f8rlie","year":"2001","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.prp.2019.02.003_bib0150","doi-asserted-by":"crossref","first-page":"8418","DOI":"10.1073\/pnas.0932692100","article-title":"Repeated observation of breast tumor subtypes in independent gene expression data sets","volume":"100","author":"Sorlie","year":"2003","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.prp.2019.02.003_bib0155","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1159\/000080280","article-title":"Prognostic value of syndecan-1 expression in breast cancer","volume":"67","author":"Leivonen","year":"2004","journal-title":"Oncology"}],"container-title":["Pathology - Research and Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0344033818317758?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0344033818317758?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,9,11]],"date-time":"2022-09-11T09:26:44Z","timestamp":1662888404000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0344033818317758"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,5]]},"references-count":31,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2019,5]]}},"alternative-id":["S0344033818317758"],"URL":"https:\/\/doi.org\/10.1016\/j.prp.2019.02.003","relation":{},"ISSN":["0344-0338"],"issn-type":[{"value":"0344-0338","type":"print"}],"subject":[],"published":{"date-parts":[[2019,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Syndecan-1 could be added to hormonal receptors and HER2\/neu in routine assessment of invasive breast carcinoma, relation of its expression to prognosis and clinicopathological parameters","name":"articletitle","label":"Article Title"},{"value":"Pathology - Research and Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.prp.2019.02.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Published by Elsevier GmbH.","name":"copyright","label":"Copyright"}]}}